Release Date: 10/03/16 16:08 Summary: Half Year Report and Accounts Price Sensitive: No Download Document 512.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%